OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Community Oncology Global Congress 2026

Donald Trump Nominates Heidi Overton as Next FDA Commissioner

From the Marathon 2024 to Olympus 2026: ELPIDA Climbs for Children with Cancer Around the World

ctDNA and MRD in NSCLC: Emerging Clinical Applications in the Immunotherapy Era

ASCO 2026 Guideline: A Risk-Adapted Framework for Early HR-Positive, HER2-Negative Breast Cancer

Pancreatic Cancer FDA Approval Following Landmark Trial Led by Dana-Farber

DART-PHASER: Daily Adaptive Salvage Radiotherapy in Prostate Cancer

Giannis Mountzios: A New ESMO Guide for Thoracic Cancer Care

Calculators

MASCC Risk Index Calculator (Febrile Neutropenia)

Identifies low-risk febrile neutropenia patients using the MASCC (Multinational Association for Supportive Care in Cancer) risk index.

Check if YES (0 points), leave unchecked if NO (+5 points)

Check if YES (0 points), leave unchecked if NO (+4 points)

Check if YES (0 points), leave unchecked if NO (+3 points)

Check if YES (+3 points), leave unchecked if NO (0 points)

Check if YES (+2 points), leave unchecked if NO (0 points)

MASCC Risk Index Scoring:

  • Burden of illness: No/mild = 5, Moderate = 3, Severe = 0
  • No hypotension: +5 points
  • No COPD: +4 points
  • No dehydration: +3 points
  • Solid tumor/no fungal infection: +4 points
  • Outpatient at onset: +3 points
  • Age <60 years: +2 points

Risk Classification:

  • Low risk: ≥21 points (suitable for outpatient management)
  • High risk: <21 points (requires inpatient management)